Fast delivery within 72 Hours

Exemestane ZPHC — 25 mg × 100 tablets

69 CFA

Exemestane (Aromasin®) — irreversible steroidal AI

100 film-coated tablets × 25 mg

  • Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone.
  • Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention.
  • Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols.
  • Lipid support: monitor HDL/LDL; consider omega-3 or niacin supplementation.
  • QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.

*For laboratory research use only. Not approved as a medicinal product.*

Shipping & Delivery

  • Courier delivery

Our courier will deliver to the specified address

2-3 Days

From $20

  • DHL Courier delivery

DHL courier will deliver to the specified address

2-3 Days

From $40

  • Warranty 1 year
  • Free 30-Day returns

Description

Exemestane ZPHC — 25mg

100 Film-Coated Tablets

Exemestane ZPHC is a steroidal aromatase inhibitor (AI) commonly referenced in:

  • Estrogen-regulation research
  • Endocrine-response studies
  • Hormonal pathway analysis
  • Post-cycle hormonal recovery models

Exemestane functions as an:

  • Irreversible aromatase inhibitor
  • Estrogen-suppression compound
  • Steroidal AI research agent

The product is supplied as:

  • 100 film-coated tablets
  • 25mg per tablet

Product Specifications

Specification Details
Manufacturer ZPHC
Active Ingredient Exemestane
Classification Steroidal Aromatase Inhibitor
Strength 25mg per tablet
Presentation 100 film-coated tablets
Form Oral tablets
Quality Standard ≥99% API purity (HPLC)
Manufacturing GMP-compliant tablet press
Authentication Scratch-code verification

Compound Profile

Aromatase Inhibition Research

Exemestane is commonly associated with:

  • Aromatase enzyme suppression studies
  • Estrogen-regulation pathway analysis
  • Hormonal balance and endocrine-response research

Estrogen-Control Studies

Research literature frequently references:

  • Water-retention mitigation analysis
  • Estrogen-related tissue response models
  • Hormonal recovery pathway studies

Precision Tablet Delivery

The tablet format supports:

  • Standardized dosing consistency
  • Controlled laboratory protocols
  • Predictable release characteristics

Key Features

Irreversible Steroidal AI

  • Permanently binds and deactivates aromatase enzymes in research models
  • Frequently referenced in estrogen-control studies

High-Purity Manufacturing

  • ≥99% HPLC-verified purity
  • GMP manufacturing standards

Secure Authentication System

  • Tamper-evident packaging
  • Scratch-code authenticity verification
  • Controlled batch-traceability standards

Safety Information

Potential adverse effects associated with aromatase inhibitor exposure may include:

  • Joint discomfort or dryness
  • Fatigue or reduced energy levels
  • Mood changes
  • Reduced estrogen-related protective effects
  • Lipid profile alterations
  • Bone-density concerns with prolonged exposure

Improper or unsupervised hormone modulation may increase endocrine and cardiovascular risks.

Important Medical Guidance

Hormone-related compounds should only be used:

  • Under supervision of a qualified healthcare professional
  • With appropriate hormone and lipid monitoring
  • According to local medical regulations and prescription laws

Misuse may result in serious health complications.

Storage Instructions

Condition Recommendation
Temperature Store in a cool, dry place
Moisture Protect from humidity
Light Exposure Keep away from direct sunlight
Safety Keep out of reach of children